Treatment of stress and preconditioning against stress

Details Treatment of stress and preconditioning against stress Treatment of stress and preconditioning against stress

2000-07-14

2002-08-13

Witz, Jean C. (Department: 1651)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Animal or plant cell

C435S002000, C435S366000, C435S372000

Reexamination Certificate

active

06432399

ABSTRACT:

FIELD OF INVENTION
This invention relates to the field of medicine and medical treatments. In particular, it relates to stress treatment and more specifically to a method and composition for treating mammals, including humans, in order to provide them with improved reactions and resistance to stress.
BACKGROUND AND PRIOR ART
The effects of stress on a mammal normally manifest themselves in an increase in body temperature, along with a charge in hemodynamic parameters, including an increase in heart rate and an increase in blood pressure. For patients already suffering from elevated blood pressure (hypertension, the effects of stress can therefore be particularly dangerous, since hypertension is a major risk factor for cardiovascular disease.
Stresses to which a mammal may be subjected, and which can result in these effects, can take a wide variety of physical forms. Psychological stresses induced by restraint, confinement, sudden exposure to danger, shock and the like translate into physical stresses affecting one or more organs of the body. Similarly, physical stress such as exposure to heat or cold, injury including surgical injury, over-exertion and the like, result in abnormal functioning of body organs. Stress is now recognized as a major detrimental factor in many diseases such as cardiovascular disease, cancer, and immunological dysfunction. Common physiological events which appear to underlie all stress responses include the induction and upregulation of synthesis, in all body cells, of a group of specialized intracellular proteins known as heat stress proteins or heat shock proteins (HSP's). These HSP's function to protect the cells from potential damage caused by whatever form of stress is being applied.
One particular species of physical stress is ischemia, which is the deprivation of oxygen resulting from reduced blood flow. Ischemia in a body organ, if severe enough, causes the eventual death of cells in the organ. Re-perfusion of the ischemic organ by resumption of blood flow thereto often results in further injury to the organ due to inflammation, and does not invigorate already injured cells. Repeated application of mild ischemic stress to an organ often leads to an increased ability to withstand stress ischemia, an effect thought to be partially related to upregulated synthesis of HSPs. Ischemia may occur as a pathological condition, e.g. as the result of spasm, thrombosis, or other blood vessel obstruction. Ischemia may be deliberately induced by clamping of blood vessels during surgery.
It is known to precondition the body of a mammalian patient by subjecting it to controlled stresses, so as better to equip the body for subsequent encounters with uncontrolled stresses of the same type. Physical exercise and training, for example, equips a body for better handling of physical exertion stresses. Heating a body or a body organ repeatedly under controlled conditions has been shown to provide the body or body organ with preconditioning for the better handling of subsequent heat stresses. Even in respect of ischemia, a body organ such as the heart which has previously suffered mild ischemia is better able to resist the effects of later ischemia, of the type causing myocardial infarction. As stated by Gersh et al., “Preconditioning is an important phenomenon, probably with clinical implications, because repetitive anginal episodes in patients may develop into full fledged infarction. Patients with pre-infarction angina may suffer from a less severe infarct than those thought to undergo sudden coronary occlusion without the opportunity for preconditioning. In contrast, patients with multiple short-lived attacks of ischemia might become tolerant through the development of protective preconditioning, according to animal data.”
1
Preconditioning by subsection to heat or ischemia is however clearly impractical in respect of most mammalian bodies and body organs.
U.S. Pat. No. 4.968.483 Mueller et al., describes an apparatus for oxygenating blood, by treating an aliquot of a patient's blood, extracorporeally, with an oxygen/ozone mixture and ultraviolet light, at a controlled temperature. The apparatus is proposed for use in hematological oxidation therapy.
U.S. Pat. No. 5,591,457 Bolton, discloses a method of inhibiting the aggregation of blood platelets in a human, a method of stimulating the immune system and a method of treating peripheral vascular diseases such as Raynaud's disease, by extracting an aliquot of blood from a patient, subjecting it to ozone/oxygen gas mixture and ultraviolet radiation at a temperature in the range of about 37-43° C., and then reinjecting the treated blood into the human patient.
International Patent Application PCT/GB93/00259 Bolton, describes a similar process for increasing the content of nitric oxide in the blood of a mammalian patient, potentially useful in treating conditions such as high blood pressure in mammalian patients.
SUMMARY OF THE INVENTION
It is an object of the present invention to provide a novel method of treating stress in a mammalian patient.
It is a further object to provide a process of preconditioning a mammalian patient to improve the patient's resistance and reaction to subsequently encountered stress.
It: is a further and important object of the invention to provide a means of protecting target organs against ischemia/reperfusion injury.
The present invention is based upon the discovery that an aliquot of a patient's blood, subjected extracorporeally to one or more stressors and then re-injected into the patient, has beneficial effects on the patient's subsequent abilities to withstand the adverse effects of subsequently encountered stresses, as well as beneficial effects on the symptoms of stress. According to the present information, application of selected stressors to the blood aliquot extracorporeally appears to cause changes in certain of the blood cells of the aliquot. It exerts beneficial effects [to] on the patient's blood including the increased resistance to subsequently encountered stresses as reported in more detail hereinafter.
Accordingly, from one aspect, the present invention provides a process of treating a mammalian patient to counteract the adverse effects of stress and/or to precondition the patient for improved resistance and reaction to subsequently encounter stress, which comprises extracting from the patient an aliquot of blood, subjecting the aliquot to extracorporeal application of one or more stressors thereto, and reinjecting the treated blood aliquot into the patient.
Stressors which can accordingly be used in the present invention, include oxidative stressors, heat stressors -and ultraviolet radiation. alone or in combinations of two or three of such stressors, and applied simultaneously or sequentially to the blood aliquot. Thus according to a more specific aspect of the present invention, there is provided a process of treating a mammalian patient to counteract the adverse effects of stress and/or to precondition the patient for improved resistance and reaction to subsequently encountered stress, which comprises extracting from the patient an aliquot of blood, subjecting the extracted blood aliquot extracorporeally to at least one stressor selected from an oxidative environment, UV radiation and elevated temperature, and reinjecting at least a portion of the treated blood aliquot into the patient.


REFERENCES:
patent: 4968483 (1990-11-01), Mueller et al.
patent: 5591457 (1997-01-01), Bolton
patent: 5891653 (1999-04-01), Attfield
patent: 5906636 (1999-05-01), Casscells, III et al.
patent: 1068428 (1957-05-01), None
patent: 93/15778 (1993-08-01), None
patent: 96/34613 (1996-11-01), None
Malinovskaia et al., Likarska Sprava 1: 1019-5297 (Jan. 1993). Abstract.*
Kupnovitskaia, Likarska Sprava 7: 27-29 (Jul. 1992). Abstract.*
Ganelina et al., Folia Haematol (Leipz) 109(3): 470-482. Abstract. 1.*
Sirenko et al., Likarska Sprava 0(8): 52-55 (1993). Abstract.*
Sirenko et al., Vrach Delo 0(10): 9-11 (1990). Abstract.*
Hernandez et al.

Affiliated with

Also associated with

Rating

Treatment of stress and preconditioning against stress does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of stress and preconditioning against stress, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of stress and preconditioning against stress will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2911879